{"id":7684,"date":"2026-05-10T17:52:34","date_gmt":"2026-05-10T15:52:34","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=7684"},"modified":"2026-06-02T18:15:34","modified_gmt":"2026-06-02T16:15:34","slug":"saa","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/saa\/","title":{"rendered":"Serum Amyloid A (SAA)\u200b"},"content":{"rendered":"\t\t
PDB ID: 4IP8. Source: RCSB Protein Data Bank. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
The VeriLumenTM<\/sup> SAA\u00a0Rapid Test\u00a0is an in vitro fluorescence immunochromatographic assay for the quantitative detection of serum amyloid A (SAA) in human whole blood, plasma, or serum. SAA is an acute-phase protein that increases rapidly in response to inflammation and is used as a sensitive, non-specific marker of inflammatory activity and tissue injury. The fluorescence-based assay provides rapid quantitative results to support timely clinical evaluation in laboratory and point-of-care settings.<\/p> This test is intended to assist in the assessment of inflammatory and infectious conditions, including bacterial infections and systemic inflammatory responses, supporting clinical evaluation and patient management decisions when interpreted together with clinical findings and other laboratory data. Quantitative SAA measurement may also aid in monitoring disease progression and response to treatment in acute care settings.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t